Differential Requirements for Protection against Mucosal Challenge with Francisella tularensis in the Presence versus Absence of Cholera Toxin B and Inactivated F. tularensis

被引:22
作者
Bitsaktsis, Constantine [1 ]
Rawool, Deepak B. [2 ]
Li, Ying [1 ]
Kurkure, Nitin V. [3 ]
Iglesias, Bibiana [1 ]
Gosselin, Edmund I. [1 ]
机构
[1] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA
[2] Univ Giessen, Inst Med Microbiol, Giessen, Germany
[3] Maharashtra Anim & Fishery Sci Univ, Nagpur Vet Coll, Nagpur, Maharashtra, India
基金
美国国家卫生研究院;
关键词
LIVE VACCINE STRAIN; VIRULENT TYPE-A; SYSTEMIC ANTIBODY-RESPONSES; MYCOBACTERIUM-BOVIS-BCG; NECROSIS-FACTOR-ALPHA; CD4(+) T-CELLS; IMMUNE-RESPONSES; GAMMA-INTERFERON; INTRANASAL IMMUNIZATION; PNEUMOCOCCAL COLONIZATION;
D O I
10.4049/jimmunol.0803242
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Francisella tularensis is a category A biothreat agent for which there is no approved vaccine and the correlates of protection are not well understood. In particular, the relationship between the humoral and cellular immune response to F. tularensis and the relative importance of each in protection is controversial. Yet, understanding this relationship will be crucial to the development of an effective vaccine against this organism. We demonstrate, for the first time, a differential requirement for Immoral vs cellular immunity in vaccine-induced protection against F. tularensis infection, and that the requirement for Ab observed in some protection studies, may be overcome through the induction of enhanced cellular immunity. Specifically, following intranasal/mucosal immunization of mice with inactivated F. tularensis organisms plus the cholera toxin B subunit, we observe increased production of IgG2a/2c vs IgG1 Ab, as well as IFN-gamma, indicating induction of a Th1 response. In addition, the requirement for F. tularensis-specific IgA Ab production, observed in studies following immunization with inactivated F. tularensis alone, is eliminated. Thus, these data indicate that enhanced Th1 responses can supersede the requirement for anti-F. tularensis-specific IgA. This observation also has important ramifications for vaccine development against this organism. The Journal of Immunology, 2009, 182: 4899-4909.
引用
收藏
页码:4899 / 4909
页数:11
相关论文
共 70 条
[1]   Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses [J].
Anjuère, F ;
George-Chandy, A ;
Audant, F ;
Rousseau, D ;
Holmgren, J ;
Czerkinsky, C .
JOURNAL OF IMMUNOLOGY, 2003, 170 (03) :1586-1592
[2]   THE REQUIREMENT FOR GAMMA INTERFERON IN RESISTANCE OF MICE TO EXPERIMENTAL TULAREMIA [J].
ANTHONY, LSD ;
GHADIRIAN, E ;
NESTEL, FP ;
KONGSHAVN, PAL .
MICROBIAL PATHOGENESIS, 1989, 7 (06) :421-428
[3]   Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity [J].
Arulanandam, BP ;
O'Toole, M ;
Metzger, DW .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) :940-949
[4]   An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain [J].
Bakshi, Chandra Shekhar ;
Malik, Meenakshi ;
Mahawar, Manish ;
Kirimanjeswara, Girish S. ;
Hazlett, Karsten R. O. ;
Palmer, Lance E. ;
Furie, Martha B. ;
Singh, Rajendra ;
Melendez, J. Andres ;
Sellati, Timothy J. ;
Metzger, Dennis W. .
VACCINE, 2008, 26 (41) :5276-5288
[5]   Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion [J].
Baron, Shawn D. ;
Singh, Rajendra ;
Metzger, Dennis W. .
INFECTION AND IMMUNITY, 2007, 75 (05) :2152-2162
[6]   Antibody-independent, CD4+ T-Cell-Dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins [J].
Basset, Alan ;
Thompson, Claudette M. ;
Hollingshead, Susan K. ;
Briles, David E. ;
Ades, Edwin W. ;
Lipsitch, Marc ;
Malley, Richard .
INFECTION AND IMMUNITY, 2007, 75 (11) :5460-5464
[7]   LOCAL AND SYSTEMIC ANTIBODY-RESPONSES TO DEXTRAN-CHOLERA TOXIN B-SUBUNIT CONJUGATES [J].
BERGQUIST, C ;
LAGERGARD, T ;
LINDBLAD, M ;
HOLMGREN, J .
INFECTION AND IMMUNITY, 1995, 63 (05) :2021-2025
[8]   Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina [J].
Bergquist, C ;
Johansson, EL ;
Lagergard, T ;
Holmgren, J ;
Rudin, A .
INFECTION AND IMMUNITY, 1997, 65 (07) :2676-2684
[9]   Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor β1 and β2 chain expression [J].
Braun, MC ;
He, JP ;
Wu, CY ;
Kelsall, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (03) :541-552
[10]   Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses [J].
Bublin, Merima ;
Hoflehner, Elisabeth ;
Wagner, Birgit ;
Radauer, Christian ;
Wagner, Stefan ;
Hufnagl, Karin ;
Allwardt, Dorothee ;
Kundi, Michael ;
Scheiner, Otto ;
Wiedermann, Ursula ;
Breiteneder, Heirno .
VACCINE, 2007, 25 (50) :8395-8404